" They got 20 years of research all together in one scoop," said Dr. Carlos Paya, chief executive of Immune Design, which is pursuing a different approach. But government officials say few, if any, other companies were interested in the technology at the time Dr. Belldegrun came calling. Dr. Rosenberg said that before Kite, a few companies, including Johnson   